In mice, disruption of the circadian clock by gene targeting of the positive regulators of circadian rhythm Bmal1 and Clock accelerates atherosclerosis progression [135] and cardiomyopathy [136], respectively. The gene discussed is BMAL1; the disease is cardiomyopathy.